AnalyzeDirect Matthew R. Schuelke et al. Diverse immunotherapies can effectively treat syngeneic brainstem tumors in the absence of overt toxicity. Journal for ImmunoTherapy of Cancer.
Publication Date
July 17, 2019
How Analyze was Used
“T1 and T2 MRI images were acquired using a Bruker DRX-300 (300 MHz 1H) 7-Tesla vertical bore small animal imaging system as described. Analyze 11.0 software was used by blinded reviewers for image analysis.”
Keywords
Immunotherapies, Syngeneic brainstem tumors, Toxicity, Anti-tumor immune responses
Author Affiliation(s)
Mayo Clinic, Rochester, Minnesota, USA
